Glaukos Net Profit Margin 2014-2022 | GKOS

Glaukos net profit margin from 2014 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
Glaukos Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2022-03-31 $0.29B $-0.03B -9.52%
2021-12-31 $0.29B $-0.05B -16.67%
2021-09-30 $0.29B $-0.04B -12.93%
2021-06-30 $0.28B $-0.06B -21.13%
2021-03-31 $0.24B $-0.08B -34.87%
2020-12-31 $0.23B $-0.12B -53.78%
2020-09-30 $0.22B $-0.07B -33.49%
2020-06-30 $0.21B $-0.07B -33.49%
2020-03-31 $0.24B $-0.04B -15.48%
2019-12-31 $0.24B $0.02B 6.72%
2019-09-30 $0.23B $-0.02B -8.41%
2019-06-30 $0.21B $-0.01B -5.69%
2019-03-31 $0.20B $-0.01B -5.64%
2018-12-31 $0.18B $-0.01B -7.18%
2018-09-30 $0.17B $-0.01B -8.28%
2018-06-30 $0.17B $-0.01B -3.64%
2018-03-31 $0.16B $-0.00B -2.45%
2017-12-31 $0.16B 0 0.00%
2017-09-30 $0.15B $-0.00B -0.67%
2017-06-30 $0.14B $-0.00B -0.71%
2017-03-31 $0.13B $0.00B 3.13%
2016-12-31 $0.12B $0.00B 3.48%
2016-09-30 $0.10B $0.00B 1.96%
2016-06-30 $0.09B $-0.00B -1.10%
2016-03-31 $0.08B $-0.04B -43.75%
2015-12-31 $0.07B $-0.04B -51.39%
2015-09-30 $0.07B $-0.04B -60.61%
2015-06-30 $0.06B $-0.04B -66.10%
2015-03-31 $0.05B $-0.01B -17.31%
2014-12-31 $0.05B $-0.01B -26.67%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.256B $0.294B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.627B 21.80
Edwards Lifesciences (EW) United States $60.552B 42.53
Alcon (ALC) Switzerland $35.080B 30.59
STERIS (STE) Ireland $21.113B 26.67
Fresenius Medical Care AG KGaA (FMS) Germany $14.716B 13.22
Teleflex (TFX) United States $11.964B 19.12
Globus Medical (GMED) United States $5.873B 29.30
Penumbra (PEN) United States $4.736B 299.29
Integer Holdings (ITGR) United States $2.383B 18.51
Nevro (NVRO) United States $1.608B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.313B 23.51
Paragon 28 (FNA) United States $1.281B 0.00
Artivion (AORT) United States $0.772B 83.52